MARKETSSTORY 520· JULY 17, 2026

Investors in ADMA Biologics reminded of class action deadlines

Investors who took losses on a Nasdaq-listed stock are being reminded that legal deadlines in an active case are approaching. A class action, a lawsuit that lets a group of plaintiffs with simil

NDNewsDialy Desk1 MIN READ

SOURCE

prnewswire.com

← PREVIOUS STORY 519Access to testosterone medication in the U.S. draws scrutiny in health media NEXT STORY 521 →GPGI, Inc. investors face a class action deadline as Pomerantz LLP files suit

Keep reading

More from the desk.

61MARKETS

Three Temasek India bets each jump more than 30% after listings this week

A contrarian bet is a position placed against the prevailing market view on an asset, held until that view shifts. Singapore's state investor Temasek made those calls on three companies in India. This week, each of them jumped more than…

markets1 MIN

90MARKETS

Bridgewater trims Amazon as it adds to Shell and PG&E

Big money shifted its holdings last quarter, tilting away from technology and toward energy. Holdings, meaning the shares a fund owns at the end of a reporting period, grew for Shell and PG&E at Bridgewater Associates during the second…

markets1 MIN

99MARKETS

Pershing Square narrows its book to three names: Uber, Brookfield, and Microsoft

Concentration, in portfolio management, means putting most of a fund's capital into a small number of positions rather than spreading it across many names. Pershing Square has organized its

markets1 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk